Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus
Open Access
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology Symposium Proceedings
- Vol. 18 (2) , S57-S63
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosusArthritis Research & Therapy, 2012
- The interferon‐regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index scoreBritish Journal of Dermatology, 2012
- Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patientsArthritis Research & Therapy, 2012
- Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across DiseasesPLOS ONE, 2012
- Quality of life in dermatomyositisJournal of the American Academy of Dermatology, 2011
- Response to Antimalarial Agents in Cutaneous Lupus ErythematosusArchives of Dermatology, 2011
- Quality of life in cutaneous lupus erythematosusJournal of the American Academy of Dermatology, 2011
- Modification of the Cutaneous Dermatomyositis Disease Area and Severity Index, an outcome instrumentBritish Journal of Dermatology, 2009
- Cross-sectional Analysis of a Collaborative Web-Based Database for Lupus Erythematosus–Associated Skin LesionsArchives of Dermatology, 2009
- The Cutaneous Lupus Erythematosus Disease Area and Severity IndexArchives of Dermatology, 2008